Works in Cellular Oncology (2211-3428), 2024, Vol 47, Issue 6
Results: 29
Inhibition of EREG/ErbB/ERK by Astragaloside IV reversed taxol-resistance of non-small cell lung cancer through attenuation of stemness via TGFβ and Hedgehog signal pathway.
- Published in:
- Cellular Oncology (2211-3428), 2024, v. 47, n. 6, p. 2201, doi. 10.1007/s13402-024-00999-7
- By:
- Publication type:
- Article
Non-glycanated ΔDCN isoform in muscle invasive bladder cancer mediates cancer stemness and gemcitabine resistance.
- Published in:
- Cellular Oncology (2211-3428), 2024, v. 47, n. 6, p. 2163, doi. 10.1007/s13402-024-00998-8
- By:
- Publication type:
- Article
Unveiling therapeutic avenues targeting xCT in head and neck cancer.
- Published in:
- Cellular Oncology (2211-3428), 2024, v. 47, n. 6, p. 2019, doi. 10.1007/s13402-024-00997-9
- By:
- Publication type:
- Article
Integrating bulk and single-cell transcriptomics to elucidate the role and potential mechanisms of autophagy in aging tissue.
- Published in:
- Cellular Oncology (2211-3428), 2024, v. 47, n. 6, p. 2183, doi. 10.1007/s13402-024-00996-w
- By:
- Publication type:
- Article
Tumour cell-released autophagosomes promote lung metastasis by upregulating PD-L1 expression in pulmonary vascular endothelial cells in breast cancer.
- Published in:
- Cellular Oncology (2211-3428), 2024, v. 47, n. 6, p. 2147, doi. 10.1007/s13402-024-00994-y
- By:
- Publication type:
- Article
Clinical value of <sup>18</sup>F-FDG PET/CT in patients with newly diagnosed acute leukemia.
- Published in:
- Cellular Oncology (2211-3428), 2024, v. 47, n. 6, p. 2135, doi. 10.1007/s13402-024-00993-z
- By:
- Publication type:
- Article
Circadian system disorder induced by aberrantly activated EFNB2-EPHB2 axis leads to facilitated liver metastasis in gastric cancer.
- Published in:
- Cellular Oncology (2211-3428), 2024, v. 47, n. 6, p. 2113, doi. 10.1007/s13402-024-00991-1
- By:
- Publication type:
- Article
Publisher Correction to: RAB37 suppresses the EMT, migration and invasion of gastric cancer cells by mediating autophagic degradation of β-catenin.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
GALNT6 drives lenvatinib resistance in hepatocellular carcinoma through autophagy and cancer-associated fibroblast activation.
- Published in:
- Cellular Oncology (2211-3428), 2024, v. 47, n. 6, p. 2439, doi. 10.1007/s13402-024-01032-7
- By:
- Publication type:
- Article
Correction to: Hepatic arterial infusion chemotherapy (HAIC) combined with Tislelizumab and Lenvatinib for unresectable hepatocellular carcinoma: a retrospective single-arm study.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Non-canonical function of PHGDH promotes HCC metastasis by interacting with METTL3.
- Published in:
- Cellular Oncology (2211-3428), 2024, v. 47, n. 6, p. 2427, doi. 10.1007/s13402-024-01029-2
- By:
- Publication type:
- Article
RAB37 suppresses the EMT, migration and invasion of gastric cancer cells by mediating autophagic degradation of β-catenin.
- Published in:
- Cellular Oncology (2211-3428), 2024, v. 47, n. 6, p. 2407, doi. 10.1007/s13402-024-01028-3
- By:
- Publication type:
- Article
Metabolic insights into tumor lymph node metastasis in melanoma.
- Published in:
- Cellular Oncology (2211-3428), 2024, v. 47, n. 6, p. 2099, doi. 10.1007/s13402-024-01027-4
- By:
- Publication type:
- Article
Exploring tumor microenvironment interactions and apoptosis pathways in NSCLC through spatial transcriptomics and machine learning.
- Published in:
- Cellular Oncology (2211-3428), 2024, v. 47, n. 6, p. 2383, doi. 10.1007/s13402-024-01025-6
- By:
- Publication type:
- Article
Role of BRCA1 in glioblastoma etiology.
- Published in:
- Cellular Oncology (2211-3428), 2024, v. 47, n. 6, p. 2091, doi. 10.1007/s13402-024-01024-7
- By:
- Publication type:
- Article
Regulation of AUF1 alternative splicing by hnRNPA1 and SRSF2 modulate the sensitivity of ovarian cancer cells to cisplatin.
- Published in:
- Cellular Oncology (2211-3428), 2024, v. 47, n. 6, p. 2349, doi. 10.1007/s13402-024-01023-8
- By:
- Publication type:
- Article
Targeting CA9 restricts pancreatic cancer progression through pH regulation and ROS production.
- Published in:
- Cellular Oncology (2211-3428), 2024, v. 47, n. 6, p. 2367, doi. 10.1007/s13402-024-01022-9
- By:
- Publication type:
- Article
Toxicity profiles of immunochemotherapy for gastric or gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis.
- Published in:
- Cellular Oncology (2211-3428), 2024, v. 47, n. 6, p. 2335, doi. 10.1007/s13402-024-01021-w
- By:
- Publication type:
- Article
Dysregulation of the p53 pathway provides a therapeutic target in aggressive pediatric sarcomas with stem-like traits.
- Published in:
- Cellular Oncology (2211-3428), 2024, v. 47, n. 6, p. 2317, doi. 10.1007/s13402-024-01020-x
- By:
- Publication type:
- Article
The survival prediction analysis and preliminary study of the biological function of YEATS2 in hepatocellular carcinoma.
- Published in:
- Cellular Oncology (2211-3428), 2024, v. 47, n. 6, p. 2297, doi. 10.1007/s13402-024-01019-4
- By:
- Publication type:
- Article
HNRNPH1 stabilizes FLOT2 mRNA in a non-canonical m6A-dependent manner to promote malignant progression in nasopharyngeal carcinoma.
- Published in:
- Cellular Oncology (2211-3428), 2024, v. 47, n. 6, p. 2279, doi. 10.1007/s13402-024-01016-7
- By:
- Publication type:
- Article
Hepatic arterial infusion chemotherapy (HAIC) combined with Tislelizumab and Lenvatinib for unresectable hepatocellular carcinoma: a retrospective single-arm study.
- Published in:
- Cellular Oncology (2211-3428), 2024, v. 47, n. 6, p. 2265, doi. 10.1007/s13402-024-01015-8
- By:
- Publication type:
- Article
TENT5A mediates the cancer-inhibiting effects of EGR1 by suppressing the protein stability of RPL35 in hepatocellular carcinoma.
- Published in:
- Cellular Oncology (2211-3428), 2024, v. 47, n. 6, p. 2247, doi. 10.1007/s13402-024-01014-9
- By:
- Publication type:
- Article
Regulatory mechanisms of steroid hormone receptors on gene transcription through chromatin interaction and enhancer reprogramming.
- Published in:
- Cellular Oncology (2211-3428), 2024, v. 47, n. 6, p. 2073, doi. 10.1007/s13402-024-01011-y
- By:
- Publication type:
- Article
IRE1α inhibitor reduces cisplatin resistance in ovarian cancer by modulating IRE1α/XBP1 pathway.
- Published in:
- Cellular Oncology (2211-3428), 2024, v. 47, n. 6, p. 2233, doi. 10.1007/s13402-024-01010-z
- By:
- Publication type:
- Article
Triggering immunogenic death of cancer cells by nanoparticles overcomes immunotherapy resistance.
- Published in:
- Cellular Oncology (2211-3428), 2024, v. 47, n. 6, p. 2049, doi. 10.1007/s13402-024-01009-6
- By:
- Publication type:
- Article
Retraction Note: The autocrine glycosylated-GREM1 interacts with TGFB1 to suppress TGFβ/BMP/SMAD-mediated EMT partially by inhibiting MYL9 transactivation in urinary carcinoma.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
USP28 promotes tumor progression and glycolysis by stabilizing PKM2/Hif1-α in cholangiocarcinoma.
- Published in:
- Cellular Oncology (2211-3428), 2024, v. 47, n. 6, p. 2217, doi. 10.1007/s13402-024-01002-z
- By:
- Publication type:
- Article
Mitochondria in tumor immune surveillance and tumor therapies targeting mitochondria.
- Published in:
- Cellular Oncology (2211-3428), 2024, v. 47, n. 6, p. 2031, doi. 10.1007/s13402-024-01000-1
- By:
- Publication type:
- Article